Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | F10 | P00742 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24030699 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL24030700 | 0.95 | KDM4E (0.34) | KDM4EATML3MBTL1SMN1; SMN2 | |
| SCHEMBL21716546 | 0.94 | FLT3 (0.31) | — | |
| SCHEMBL23471999 | 0.94 | FLT3 (0.31) | — | |
| SCHEMBL24030173 | 0.92 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL24030478 | 0.91 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2 | |
| SCHEMBL21213390 | 0.91 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2 | |
| SCHEMBL21213020 | 0.91 | KDM4E (0.40) | KDM4EATML3MBTL1SMN1; SMN2 | |
| SCHEMBL21717307 | 0.91 | FLT3 (0.32) | KDM4E | |
| SCHEMBL23471982 | 0.90 | KDM4E (0.32) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LAS1L, ARL1, NAP1L4 | KDM4E 1442/4885ATM 2672/4885L3MBTL1 131/4885 |
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | KDM4E 3233/4885ATM 3405/4885L3MBTL1 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.